Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Decision Diagnostics Corp. DECN OTC

Other OTC • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
32/100
0/4 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Decision Diagnostics Corp. (DECN) is a Medical - Pharmaceuticals company in the Healthcare sector, currently trading at $0.00. It has a SharesGrow Score of 29/100, indicating a weak investment profile with 0 out of 7 criteria passed.

Net profit margin is 0% (thin). Gross margin is 25.2% (-10.5 pp trend).

Balance sheet: total debt is $0 against $0 equity. Total assets: $0.

SharesGrow 7-Criteria breakdown: Value ?/100 (Fail), Growth 15/100 (Fail), Past 0/100 (Fail), Health 100/100 (Fail), Moat 14/100 (Fail), Future ?/100 (Fail), Income ?/100 (Fail).

DECN SharesGrow Score Overview

43/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 0/100
Valuation — P/E, PEG, Forward PEG
GROWTH 15/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 14/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 0/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — DECN

—
VALUE N/A
N/A
No analyst coverage available for this stock.
✗
GROWTH Fail
15/100
DECN: -58.4%/yr revenue is, -373.6%/yr Net income is average growth. weak. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
—
PAST N/A
N/A
No analyst coverage available for this stock.
✗
HEALTH Fail
100/100
Balance sheet DECN: Debt-to-Equity (D/E) ratio N/A, Current ratio is N/A. Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
✗
MOAT Fail
14/100
DECN: Gross margin is 25.2% (-10.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 14/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
—
INCOME N/A
N/A
No analyst coverage available for this stock.

Stock Chart & Stats

Market Data
52-Week Range0.0001-0.0001
Volume2M
Avg Volume (30D)1.08M
Market Cap$35.45K
Beta (1Y)-0.05
Share Statistics
IPO Date2002-02-08
Employees6
CEOKeith Berman
Financial Highlights & Ratios
Analyst Forecast
Company Info
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2434431084

Price Chart

Track all markets on TradingView
DECN
Decision Diagnostics Corp. ↗  ·  Other OTC
Healthcare • Medical - Pharmaceuticals

People Also View

ALBBY
ALBBY
Alibaba Health Information Technology Limited
$12.12
+0.00%
 ALBHF
ALBHF
Alibaba Health Information Technology Limited
$0.58
-4.26%
 HITI
HITI
High Tide Inc.
$2.34
+0.43%
 LFLY
LFLY
Leafly Holdings, Inc.
$37.00
+0.00%
 NVACF
NVACF
Nova Cannabis Inc.
$1.26
-2.77%
 PETS
PETS
PetMed Express, Inc.
$2.35
+2.17%
 RAD
RAD
Rite Aid Corporation
$0.65
-16.81%
 MEDS
MEDS
TRxADE HEALTH, Inc.
$7.59
+4.55%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message